CEO/Chairman of Applied Biosystems dumps stock before merger
When we saw that the chairman and CEO of Applied Biosystems, Tony Smith, had unloaded nearly $29 million worth of stock in three days, we knew something was up. It turns out that Mr. Smith and five other board members will no longer have a place at the company when Applied merges with competitor Invitrogen. Mr. Smith’s response was to liquidate close to one million shares.
Regardless of whether or not he’s bitter (and it looks like he is) what does it say about the merits of a merger when the CEO and Chairman of one of the companies sells most of his stock before the two companies are combined? It isn’t a strong vote of confidence…
[Finviz] Tony White’s insider trading
[Yahoo Finance] Form 8-K Departure of Directors


















